Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Germany paid the most for dextrose in Q2 2026: USD 1,032/MT, up 2.0% from USD 1,012 in Q1. The steady food and pharmaceutical demand kept things firm there. Worldwide, the average moved up 1.9%, to USD 887/MT from USD 870, largely because the corn starch feedstock costs kept climbing across every region we track. What about H2 2026? We'd expect a global average somewhere in the USD 875-950/MT range, with the steady food-manufacturing and pharmaceutical demand doing most of the work across all four regions.
Dextrose is glucose derived from corn or wheat starch through enzymatic hydrolysis, sold as a crystalline monohydrate for food use, anhydrous for applications sensitive to moisture, or pharmaceutical grade for intravenous solutions and other medical uses. It feeds a genuinely wide range of food-manufacturing applications, from confectionery and baked goods to sports-nutrition products, alongside its established role in hospital IV-fluid formulations. Three things move the price more than anything else: the corn or wheat starch feedstock costs, the food-manufacturing demand, and the pharmaceutical-sector demand for medical-grade material.
The enzymatic hydrolysis process deserves some explanation, since it's what actually converts starch into the simple sugar that food and pharmaceutical manufacturers need. Starch molecules are long chains of glucose units, and specialized enzymes break those chains down step by step until what remains is largely free glucose, or dextrose, in solution, which is then crystallized and dried into the finished product. That enzymatic conversion process is well established and highly efficient, which has kept dextrose production costs closely tied to the underlying starch feedstock rather than to any significant processing-technology premium. Buyers new to this market sometimes underestimate how much that structural detail matters until they see it play out in the pricing data over a full cycle.
The pharmaceutical application deserves particular attention, since it requires a meaningfully higher purity standard than the food-grade material that dominates this market by volume. Intravenous dextrose solutions are among the most commonly administered hospital treatments worldwide, used both as a direct energy source for patients and as a base solution for delivering other medications, which has kept pharmaceutical-grade demand a steady, dependable segment even during periods when food-sector demand has shown more variation. That distinction is worth keeping in mind for anyone comparing this market to more conventional industrial or agricultural commodities.
Supply and demand should stay moderately tight through H2 2026, with the corn and wheat starch feedstock costs doing most of the work on pricing. Germany and the US both kept the food and pharmaceutical demand steady through H1, and that's likely to continue. India's food-manufacturing sector kept the demand building, while China's large production base kept it the most affordable of the four. None of the four markets we track is showing signs of genuine disruption heading into the back half of the year.
Buyers should keep an eye on the broader corn and wheat starch markets specifically, since that's the dominant feedstock cost driver here, and any shift in grain pricing tends to flow through to dextrose within the same quarter. That's worth building into any longer-range planning rather than assuming current conditions will simply persist unchanged.
The pharmaceutical-grade segment tends to hold up more steadily than the food-manufacturing side, given how essential IV dextrose solutions are to routine hospital care regardless of broader economic conditions.
What could push prices higher? A corn or wheat starch feedstock spike, or a stronger-than-expected pharmaceutical demand surge. What could pull them lower? A slowdown in food-manufacturing activity more broadly. Buyers should watch both sides of that equation closely given how quickly conditions can shift.
| Region | 2026 Price Range (USD/MT) | Outlook |
| Global Average | 875 - 950 | Steady food and pharmaceutical demand support |
| United States | 940 - 1,020 | Steady food-manufacturing demand |
| China | 770 - 835 | Large production base keeps China most affordable |
| Germany | 1,015 - 1,100 | Established pharmaceutical demand commands premium |
| India | 835 - 905 | Growing food-manufacturing demand |
US dextrose producers passed through the firmer corn starch costs this quarter, and the domestic food-manufacturing demand held steady. The gain came to 1.9%, USD 937/MT to USD 955.
Why did the price of Dextrose change in Q2 2026 in United States?
The corn starch feedstock costs firmed through the quarter, and the domestic food-manufacturing demand held its ground right alongside that.
China climbed 1.9% to USD 778/MT, its large production base keeping it the most affordable market even as the demand firmed.
Why did the price of Dextrose change in Q2 2026 in China?
The large production base is exactly why China stayed the cheapest of the four markets even as the demand ticked up.
USD 1,032/MT. That's where Germany landed in Q2, up 2.0% from USD 1,012 in Q1. The pharmaceutical demand stayed steady, and the feedstock costs climbed just enough to push things higher.
Why did the price of Dextrose change in Q2 2026 in Germany?
The pharmaceutical demand didn't move much, honestly. It was the corn starch feedstock costs doing most of the work this quarter.
India gained 1.9% to USD 845/MT, the food-manufacturing demand continuing to build through the period.
Why did the price of Dextrose change in Q2 2026 in India?
The food-manufacturing demand kept building, and that alone explains most of the move here.
US dextrose rose 1.9% to USD 937/MT, the food-manufacturing demand firming with the new year.
Why did the price of Dextrose change in Q1 2026 in United States?
The food-manufacturing demand firmed with the new year, and the corn starch costs kept climbing steadily too.
Chinese dextrose gained 1.9% to USD 764/MT, the demand firming as the year opened.
Why did the price of Dextrose change in Q1 2026 in China?
The domestic demand firmed as the year opened, and the corn starch feedstock costs edged higher right alongside it.
German dextrose climbed 2.0% to USD 1,012/MT, the pharmaceutical demand staying firm through the quarter.
Why did the price of Dextrose change in Q1 2026 in Germany?
The pharmaceutical demand stayed firm, and the feedstock costs firmed alongside it.
Indian dextrose rose 1.9% to USD 829/MT, the food-manufacturing demand building through the quarter.
Why did the price of Dextrose change in Q1 2026 in India?
The food-manufacturing demand built through the quarter, tracking the industrial activity closely.
The global average climbed steadily across the window, from USD 820/MT in Q1 2025 to USD 887 by Q2 2026, a net gain of about 8.2%. Every quarter posted a gain here, reflecting the firming corn and wheat starch feedstock costs and the steady food and pharmaceutical demand across every market we track, with the pace of the gains picking up somewhat in the most recent two quarters. That kind of steady, uninterrupted climb is worth noting, since it stands in contrast to how choppy some other commodities in this space have looked over the same period.
| Quarter | Price (USD/MT) | QoQ Change | Direction |
| Q2 2026 | 887 | +1.9% | ↑ Rising |
| Q1 2026 | 870 | +2.0% | ↑ Rising |
| Q4 2025 | 853 | +1.3% | ↑ Rising |
| Q3 2025 | 842 | +1.3% | ↑ Rising |
| Q2 2025 | 831 | +1.3% | ↑ Rising |
| Q1 2025 | 820 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
2025 was a steadily firming year for dextrose. Starting near USD 820/MT in Q1, the global average finished 2025 at USD 853, a gain of about 4.0%. The food and pharmaceutical demand held consistent all year across every market we track, before the pace of gains picked up further once 2026 got underway. Buyers who track this market closely tend to view that steady annual pattern as the baseline against which any future quarter's move should be judged.
US prices moved from about USD 880/MT in Q1 2025 to USD 919 by Q4, up roughly 4.4%. The food-manufacturing demand held steady all year.
Chinese prices climbed from USD 720/MT in Q1 to USD 750 by Q4, a 4.2% gain, and China stayed the most affordable of the four markets throughout.
German prices rose from USD 950/MT in Q1 to USD 992 by Q4, up 4.4%, the highest absolute price throughout the four markets on the established pharmaceutical demand.
Indian prices moved from USD 780/MT in Q1 to USD 813 by Q4, a 4.2% gain, as the food-manufacturing demand kept building through the year.
Expert Market Research: Your Source for Real-Time Dextrose Price Intelligence
We keep a continuous eye on the dextrose prices wherever it's produced or consumed at scale, tracing causation through the corn and wheat starch feedstock economics, the food-manufacturing demand, and the pharmaceutical-sector demand for medical-grade material. Our analysts track the pharmaceutical and food-grade segments separately, given how differently each responds to broader economic and healthcare-demand cycles. We also flag any material shift in the underlying feedstock or trade-logistics conditions as soon as it becomes apparent. Need pricing data, bespoke market analysis, or procurement advisory? Reach out to our team.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
It feeds a genuinely wide range of food-manufacturing applications, from confectionery and baked goods to sports-nutrition products, alongside its established role in hospital IV-fluid formulations.
In Q2 2026, it averaged USD 955/MT in the US, USD 778/MT in China, USD 1,032/MT in Germany, and USD 845/MT in India, still the priciest market thanks to the established pharmaceutical demand.
The global average climbed from USD 853/MT in Q4 2025 to USD 870 in Q1 2026, then on to USD 887 in Q2, up 4.0% across the half.
The corn and wheat starch feedstock costs firmed across every region, while the food and pharmaceutical demand held steady to strong across every market tracked.
We're expecting a global average somewhere in the USD 875-950/MT range, supported by the steady food and pharmaceutical demand.
Germany carries the firmest premium on established pharmaceutical demand. The US sits close behind on steady food-manufacturing demand. China prices lowest on its large domestic production base.
The corn and wheat starch feedstock costs matter most, followed by the food-manufacturing demand and the pharmaceutical-sector demand for medical-grade material.
China holds the largest production base, while the US, Germany, and India host established producers serving their own regional food and pharmaceutical industries.
Monthly, though our analysts flag any material shift in feedstock or manufacturing-activity conditions between scheduled updates, so buyers are never working from stale figures. We also track how buyers in adjacent markets are adjusting their sourcing strategies.
The quarterly trends and forecasts help time food and pharmaceutical-linked purchasing around the corn and wheat starch feedstock cycles. Tracking grain-market trends can help buyers anticipate dextrose supply shifts before they show up in spot prices. Building that habit into a quarterly procurement review tends to pay off more consistently than reacting to price moves after they have already happened.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.